General MedicationsOPHTHALMICGeneric

NEODECADRON

DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE

Standard Dose

EQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview NEODECADRON is listed in Drugs@FDA under application 050324 (NDA).

Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM Sponsor MERCK Submission history Latest submission status date: 1996-04-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEODECADRON is listed in Drugs@FDA under application 050324 (NDA). Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM Sponsor MERCK Submission history Latest submission status date: 1996-04-16 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.